Larkspur Biosciences

📍 Watertown, United States🗓 Founded 2020👥 21 employees💰 Last funded Jan 2023
Biotechnology Research🌐 larkspur.bio
Website LinkedIn
Larkspur Biosciences is building the next precision immunotherapies to outsmart cancer. Larkspur’s approach targets the unique ways that tumors hijack the immune system by developing precision immunotherapies for molecularly defined patient populations in order to overcome these bottlenecks that allow the tumor to subvert the immune system. We are advancing our first-in-class programs to outsmart the tumor and enable robust and sustained immune responses in colorectal cancer (CRC) and beyond. LarkX, our target discovery platform, leverages tumor genetics and immune phenotypes from patient-derived data to fuel its pipeline and offers the opportunities to address multiple types of cancer. We believe that transformational discoveries are found at the interface between disciplines. With a proven track record of drug discovery and development, our team is passionate about solving hard problems and driven to deliver new medicines to cancer patients with significant unmet needs. At Larkspur, we grow together, building a culture that highly values joy, trust, and courage.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in Larkspur Biosciences?
Larkspur Biosciences has 1 investors on record on gritt.io, 1 mid-stage.
When did Larkspur Biosciences last raise funding?
The most recent investment in Larkspur Biosciences recorded on gritt.io was in January 2023.
When was Larkspur Biosciences founded?
Larkspur Biosciences was founded in 2020.
What industry is Larkspur Biosciences in?
Larkspur Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Larkspur Biosciences based?
Larkspur Biosciences is headquartered in Watertown, United States.